
Results
3
3 companies
Newron Pharmaceuticals
Market Cap: CHF 364.5m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 17.56
7D
-5.6%
1Y
114.1%
lastminute.com
Market Cap: CHF 135.9m
Operates in the online travel industry providing dynamic holiday packages in Italy, Spain, the United Kingdom, France, Germany, and internationally.
LMN
CHF 12.75
7D
-1.9%
1Y
-12.9%
Cosmo Pharmaceuticals
Market Cap: CHF 1.5b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 96.10
7D
-16.1%
1Y
77.0%